Correlation Between Ultragenyx and Incyte

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ultragenyx and Incyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ultragenyx and Incyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ultragenyx and Incyte, you can compare the effects of market volatilities on Ultragenyx and Incyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ultragenyx with a short position of Incyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ultragenyx and Incyte.

Diversification Opportunities for Ultragenyx and Incyte

-0.73
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Ultragenyx and Incyte is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Ultragenyx and Incyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Incyte and Ultragenyx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ultragenyx are associated (or correlated) with Incyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Incyte has no effect on the direction of Ultragenyx i.e., Ultragenyx and Incyte go up and down completely randomly.

Pair Corralation between Ultragenyx and Incyte

Given the investment horizon of 90 days Ultragenyx is expected to under-perform the Incyte. But the stock apears to be less risky and, when comparing its historical volatility, Ultragenyx is 1.3 times less risky than Incyte. The stock trades about -0.12 of its potential returns per unit of risk. The Incyte is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  6,631  in Incyte on September 2, 2024 and sell it today you would earn a total of  828.00  from holding Incyte or generate 12.49% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Ultragenyx  vs.  Incyte

 Performance 
       Timeline  
Ultragenyx 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ultragenyx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Incyte 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Incyte are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, Incyte showed solid returns over the last few months and may actually be approaching a breakup point.

Ultragenyx and Incyte Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ultragenyx and Incyte

The main advantage of trading using opposite Ultragenyx and Incyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ultragenyx position performs unexpectedly, Incyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Incyte will offset losses from the drop in Incyte's long position.
The idea behind Ultragenyx and Incyte pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamental Analysis
View fundamental data based on most recent published financial statements